VIRBAC CORP
10-Q, EX-27, 2000-08-15
PHARMACEUTICAL PREPARATIONS
Previous: VIRBAC CORP, 10-Q, 2000-08-15
Next: TUDOR INVESTMENT CORP ET AL, SC 13G/A, 2000-08-15



<TABLE> <S> <C>

<ARTICLE>                          5

<S>                                <C>
<PERIOD-TYPE>                      6-MOS
<FISCAL-YEAR-END>                  DEC-31-2000
<PERIOD-END>                       JUN-30-2000
<CASH>                             243,220
<SECURITIES>                       0
<RECEIVABLES>                      9,609,928
<ALLOWANCES>                       0
<INVENTORY>                        13,145,313
<CURRENT-ASSETS>                   24,341,869
<PP&E>                             12,580,013
<DEPRECIATION>                     0
<TOTAL-ASSETS>                     46,560,316
<CURRENT-LIABILITIES>              10,300,597
<BONDS>                            0
              0
                        0
<COMMON>                           212,831
<OTHER-SE>                         0
<TOTAL-LIABILITY-AND-EQUITY>       46,560,316
<SALES>                            27,134,681
<TOTAL-REVENUES>                   27,134,681
<CGS>                              7,725,542
<TOTAL-COSTS>                      9,801,596
<OTHER-EXPENSES>                   506,288
<LOSS-PROVISION>                   245,606
<INTEREST-EXPENSE>                 506,288
<INCOME-PRETAX>                    1,771,772
<INCOME-TAX>                       0
<INCOME-CONTINUING>                1,771,772
<DISCONTINUED>                     0
<EXTRAORDINARY>                    0
<CHANGES>                          0
<NET-INCOME>                       1,771,772
<EPS-BASIC>                        0.08
<EPS-DILUTED>                      0.08



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission